Vanguard Capital Management’s Upstream Bio UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.3M Buy
1,959,338
+82,604
+4% +$541K ﹤0.01% 2736
2026
Q2
$13M Buy
1,876,734
+3,160
+0.2% +$26.5K ﹤0.01% 2678
2026
Q1
$16.9M Buy
+1,873,574
New +$33.7M ﹤0.01% 2443

Other funds holding UPB

Vanguard Capital Management's UPB Position: Q3 2026 in Review

Vanguard Capital Management increased its Upstream Bio (UPB) stake by 4.4% in Q3 2026, buying an estimated $541K and bringing the position to 1,959,338 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2736.

Vanguard Capital Management first reported a position in UPB in Q1 2026 and has held it in 3 quarters since. The position peaked at $16.9M in Q1 2026. 135 funds tracked by Wall St. Rank hold UPB as of Q3 2026.

  • Vanguard Capital Management held 1,959,338 shares of Upstream Bio worth $10.3M as of Q3 2026.
  • Vanguard Capital Management bought 82,604 Upstream Bio shares in Q3 2026, an estimated $541K.
  • Upstream Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2736 holding.
  • Vanguard Capital Management first reported a position in Upstream Bio in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Upstream Bio position peaked at $16.9M in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.